Study raises questions about prostate cancer therapies targeting IGF-1
Friday, May 2, 2008 - 13:14
in Health & Medicine
Therapies under development to treat prostate cancer by inhibiting the ability of insulin-like growth factor (IGF-1) to activate its target receptor could have unexpected results especially if a major tumour suppressor gene - p53 - is already compromised, according to new research by investigators at Fred Hutchinson Cancer Research Centre...
Read the whole article on Science Centric
More from Science Centric
Related
- Study raises questions about prostate cancer therapies targeting IGF-1Thu, 1 May 2008, 0:28:24 EDT
- A potential new target for treatment of hormone refractory prostate cancerMon, 6 Apr 2009, 12:22:28 EDT
- Researchers identify promising cancer drug target in prostate tumorsThu, 26 Jun 2008, 11:29:44 EDT
- Age alone should not be used to determine whether to treat prostate cancer with hormonesWed, 24 Sep 2008, 11:31:03 EDT
- Experimental insulin-like growth factor receptor inhibitor reduced pancreatic cancer growthTue, 14 Apr 2009, 13:49:41 EDT